SYNDAX PHARMACEUTICALS INC (SNDX) Institutional Ownership and Insiders Activity
SYNDAX PHARMACEUTICALS INC (SNDX) is widely held by institutional investors, with 235 firms reporting positions valued at approximately $2.31B based on SEC Form 13F filings for the quarter ended June 30, 2026.
Blackrock, Inc. is the largest disclosed holder, reporting approximately $197.18M in SNDX holdings in its latest filing.
Institutional Holders
235
Total Reported Value
$2.31B
Largest Holder
Blackrock, Inc.
Largest Position
$197.18M
Insider Transactions (90d)
0
Latest Filing Quarter
Q2 2026
New Institutional Positions
37
Funds Exiting Positions
46
Top Institutional Owners
View allInvestorReported Balance
- Blackrock, Inc.$197.18M
- Kynam Capital Management, Lp$175.99M
- Goldman Sachs Group Inc$128.13M
- State Street Corp$123.69M
- Bank Of America Corp$88.43M
SNDX News
All news- Kingdon Capital Management Portfolio Changes in Q2 2026
Aug 17, 2026 · valut.ai
Related SNDX Institutional Insights:
- SNDX 13F Institutional Holders
- SNDX Superinvestors
- SNDX Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- SNDX Insider Trading & SEC Form 4 Activity
- SNDX Articles
- Top Institutional Investor Stock Rankings